La Nación / Borba travels to the US to negotiate J&J vaccines, of a single dose

The head of the Ministry of Health, Dr. Julio Borba, will undertake a trip this weekend to the United States in an official transfer to directly negotiate the Janssen vaccines against the coronavirus, with the Johnson & Johnson laboratory.

“This weekend I am traveling to New Jersey to see what is related to the negotiations of the Janssen vaccines, from the Johnson & Johnson laboratory,” revealed the head of the health portfolio in an interview he had with the radio station 800 Am.

The high official did not give details of under what conditions the purchase of the inoculants would be negotiated; neither terms nor quantities. The biological Janssen requires only one dose of application to grant immunity against the virus.

Also read: From Saturday the Pfizer vaccines can already be applied

It is typical of the Johnson & Johnson company, which, unlike other pharmaceutical companies, produced this vaccine to be administered in a single dose, being as effective and safe as the rest of the vaccines.

Janssen was developed through the scientific method called viral vector, the same technology used to produce the AstraZeneca vaccine, that is, it uses a harmless version of a virus to train the immune system to identify and defend against it.

The pharmaceutical company tested its efficacy and safety during phases I and II of development of the biological, applying both one and two doses to a certain group of people and the results showed that, due to the technology it uses, 29 days after administering At the first dose, 90% of people developed antibodies, while 100% developed them at 57 days.

This means that the second dose is not so necessary, since only with the first a high percentage of immunity is acquired.

You can read: Borba: vaccination will advance for the military, police, teachers, firefighters

The efficacy and safety of Janssen is also endorsed by the European Medicines Agency, EMA, an entity that guarantees the scientific evaluation, supervision and monitoring of the safety of medicines for human use such as vaccines, and was added by the World Health Organization, WHO, to the list of effective and safe vaccines against COVID-19.

If its purchase and arrival in Paraguay is completed, it would become the eighth vaccine to enter the country after the Russian Sputnik V, AstraZeneca, Moderna, Sinopharm, Sinovac, Covaxin and Pfizer (which arrives this weekend).

– .